دورية أكاديمية
The Major Chromoblastomycosis Etiologic Agent Fonsecaea pedrosoi Activates the NLRP3 Inflammasome.
العنوان: | The Major Chromoblastomycosis Etiologic Agent Fonsecaea pedrosoi Activates the NLRP3 Inflammasome. |
---|---|
المؤلفون: | de Castro RJA; Laboratory of Applied Immunology, Department of Cellular Biology, Institute of Biological Sciences, University of Brasília, Brasília, Brazil., Siqueira IM; Laboratory of Applied Immunology, Department of Cellular Biology, Institute of Biological Sciences, University of Brasília, Brasília, Brazil., Jerônimo MS; Laboratory of Applied Immunology, Department of Cellular Biology, Institute of Biological Sciences, University of Brasília, Brasília, Brazil., Basso AMM; Laboratory of Applied Immunology, Department of Cellular Biology, Institute of Biological Sciences, University of Brasília, Brasília, Brazil., Veloso Junior PHH; Laboratory of Applied Immunology, Department of Cellular Biology, Institute of Biological Sciences, University of Brasília, Brasília, Brazil., Magalhães KG; Laboratory of Immunology and Inflammation, Department of Cellular Biology, Institute of Biological Sciences, University of Brasília, Brasília, Brazil., Leonhardt LC; Laboratory of Applied Immunology, Department of Cellular Biology, Institute of Biological Sciences, University of Brasília, Brasília, Brazil., de Oliveira SAM; Laboratory of Applied Immunology, Department of Cellular Biology, Institute of Biological Sciences, University of Brasília, Brasília, Brazil., Bürgel PH; Laboratory of Applied Immunology, Department of Cellular Biology, Institute of Biological Sciences, University of Brasília, Brasília, Brazil., Tavares AH; Laboratory of Applied Immunology, Department of Cellular Biology, Institute of Biological Sciences, University of Brasília, Brasília, Brazil., Bocca AL; Laboratory of Applied Immunology, Department of Cellular Biology, Institute of Biological Sciences, University of Brasília, Brasília, Brazil. |
المصدر: | Frontiers in immunology [Front Immunol] 2017 Nov 20; Vol. 8, pp. 1572. Date of Electronic Publication: 2017 Nov 20 (Print Publication: 2017). |
نوع المنشور: | Journal Article |
اللغة: | English |
بيانات الدورية: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Print ISSN: 1664-3224 (Print) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: PubMed not MEDLINE |
أسماء مطبوعة: | Original Publication: [Lausanne : Frontiers Research Foundation] |
مستخلص: | Fonsecaea pedrosoi is the main etiologic agent of chromoblastomycosis (CBM), one of the most prevalent subcutaneous mycosis in tropical and subtropical countries. CBM is a poorly characterized chronic infection that commonly starts after transcutaneous inoculation of conidia and saprophytic hyphae of F. pedrosoi . Recently, we have shown that unlike conidia, hyphae and muriform cells (the parasitic morphotype) of F. pedrosoi promotes an intense inflammatory response pattern in vivo , which comprises the production of an inflammasome-derived cytokine, IL-1β. Nonetheless, the mechanisms underlying IL-1β production and maturation upon F. pedrosoi infection and its functional output in the course of CBM remains unknown. We show here that F. pedrosoi hyphae, differently from conidia, induce IL-1β secretion in both bone marrow-derived dendritic cells and macrophages. Using inhibitors and knockout cells, we demonstrated that the mechanisms underlying IL-1β production by hyphae-infected macrophages were dependent on dectin-1, -2, and -3 receptors and the Syk-NF-kB signaling pathway. Furthermore, F. pedrosoi promoted a NLRP3-dependent inflammasome activation, which required potassium efflux, reactive oxygen species production, phagolysosomal acidification, and cathepsin B release as triggers. IL-1β processing and release was mediated primarily by caspase-1 and, to a lesser extent, by caspase-8-dependent cleavage. Finally, we showed using a murine CBM model that F. pedrosoi elicits a NLRP3-regulated IL-1β and interleukin-18 release in vivo , but without NLRP3 inflammasome activation interfering in the course of the experimental infection. |
References: | PLoS Pathog. 2017 Jul 3;13(7):e1006485. (PMID: 28671985) J Immunol. 2015 May 1;194(9):4507-17. (PMID: 25825440) EMBO Mol Med. 2013 Jun;5(6):814-26. (PMID: 23666718) PLoS One. 2010 Apr 02;5(4):e10008. (PMID: 20368800) J Immunol. 2011 Feb 15;186(4):2529-34. (PMID: 21257968) FEMS Microbiol Rev. 2007 Sep;31(5):570-91. (PMID: 17645522) Immunity. 2013 Sep 19;39(3):432-41. (PMID: 24054327) PLoS One. 2014 Dec 09;9(12):e114113. (PMID: 25490199) J Immunol. 2013 Jan 1;190(1):334-9. (PMID: 23225887) Clin Dermatol. 2007 Mar-Apr;25(2):188-94. (PMID: 17350498) Cell Res. 2013 Jul;23 (7):965-8. (PMID: 23567555) PLoS Pathog. 2005 Nov;1(3):e30. (PMID: 16304610) Immunity. 2013 Jun 27;38(6):1142-53. (PMID: 23809161) Am J Trop Med Hyg. 1989 Jun;40(6):651-8. (PMID: 2742041) J Immunol Methods. 1999 Feb 1;223(1):77-92. (PMID: 10037236) Cell Host Microbe. 2014 Apr 9;15(4):494-505. (PMID: 24721577) Virchows Arch A Pathol Anat Histopathol. 1993;422(4):285-91. (PMID: 8506621) Methods. 2001 Dec;25(4):402-8. (PMID: 11846609) Cell Host Microbe. 2011 May 19;9(5):436-43. (PMID: 21575914) Immunity. 2013 Aug 22;39(2):324-34. (PMID: 23911656) Eukaryot Cell. 2014 Feb;13(2):329-40. (PMID: 24376002) PLoS Pathog. 2011 Dec;7(12 ):e1002379. (PMID: 22174673) J Immunol. 2009 Sep 15;183(6):3578-81. (PMID: 19684085) Rev Inst Med Trop Sao Paulo. 2015 Sep;57 Suppl 19:46-50. (PMID: 26465369) Cell Microbiol. 2007 Feb;9(2):368-81. (PMID: 16953804) J Immunol. 2012 Oct 15;189(8):4175-81. (PMID: 22984082) Nat Rev Microbiol. 2016 Mar;14(3):163-76. (PMID: 26853116) Exp Dermatol. 2014 Dec;23 (12 ):884-9. (PMID: 25267545) PLoS Negl Trop Dis. 2013 Dec 05;7(12 ):e2595. (PMID: 24340123) Eur J Immunol. 2015 Sep;45(9):2542-52. (PMID: 26140582) Cell Host Microbe. 2009 May 8;5(5):487-97. (PMID: 19454352) J Infect Dis. 2006 May 15;193(10):1419-26. (PMID: 16619190) Cell. 2010 Mar 19;140(6):821-32. (PMID: 20303873) Scand J Immunol. 2006 Dec;64(6):595-600. (PMID: 17083615) Nat Immunol. 2009 Feb;10 (2):203-13. (PMID: 19122653) Nat Immunol. 2012 Jan 22;13(3):246-54. (PMID: 22267217) Infect Immun. 2014 Feb;82(2):882-92. (PMID: 24478101) Cell Mol Immunol. 2016 Mar;13(2):148-59. (PMID: 26549800) Arch Dermatol. 1987 Oct;123(10):1300-2. (PMID: 3662560) Mycoses. 2001;44(1-2):1-7. (PMID: 11398635) Mycopathologia. 1994 May;126(2):85-91. (PMID: 8065435) Virchows Arch A Pathol Anat Histol. 1982;397(2):203-14. (PMID: 7179738) J Immunol. 2009 Jul 15;183(2):787-91. (PMID: 19570822) Cell Host Microbe. 2015 Mar 11;17 (3):357-68. (PMID: 25704009) PLoS Negl Trop Dis. 2017 Mar 29;11(3):e0005461. (PMID: 28355277) Protein Cell. 2013 Jul;4(7):529-38. (PMID: 23686720) Infect Immun. 2015 Dec 14;84(3):635-42. (PMID: 26667836) J Med Vet Mycol. 1990;28(5):373-83. (PMID: 2283584) Rev Inst Med Trop Sao Paulo. 2004 Jan-Feb;46(1):33-6. (PMID: 15057332) Nat Immunol. 2012 Sep;13(9):817-22. (PMID: 22910394) J Immunol. 2011 Jul 15;187(2):613-7. (PMID: 21677136) PLoS Pathog. 2015 Jul 23;11(7):e1004948. (PMID: 26204108) Innate Immun. 2016 Jul;22(5):316-24. (PMID: 27189427) J Exp Med. 2003 May 5;197(9):1107-17. (PMID: 12719479) Immunol Rev. 2015 May;265(1):172-80. (PMID: 25879292) Microbes Infect. 2014 Oct;16(10 ):845-54. (PMID: 25193031) Curr Pharm Biotechnol. 2000 Nov;1(3):235-51. (PMID: 11469382) J Cutan Pathol. 2017 Nov;44(11):915-918. (PMID: 28753235) Front Immunol. 2017 Jul 10;8:786. (PMID: 28740491) Cell Metab. 2015 Apr 7;21(4):513-4. (PMID: 25863243) Mycopathologia. 2006 Apr;161(4):195-203. (PMID: 16552481) J Immunol. 2015 Nov 15;195(10 ):4962-72. (PMID: 26466953) Clin Microbiol Rev. 2017 Jan;30(1):233-276. (PMID: 27856522) MBio. 2012 Dec 26;4(1):e00433-12. (PMID: 23269828) Med Mycol. 2009 Feb;47(1):3-15. (PMID: 19085206) J Med Vet Mycol. 1996 Sep-Oct;34(5):323-30. (PMID: 8912165) Nature. 2009 May 21;459(7245):433-6. (PMID: 19339971) Scand J Immunol. 2006 Oct;64(4):382-7. (PMID: 16970678) Immunity. 2010 May 28;32(5):681-91. (PMID: 20493731) Cell Rep. 2014 Jan 16;6(1):196-210. (PMID: 24388751) |
فهرسة مساهمة: | Keywords: Fonsecaea pedrosoi; NLRP3 inflammasome; chromoblastomycosis; dendritic cells; hyphae; macrophages |
تواريخ الأحداث: | Date Created: 20171207 Latest Revision: 20191120 |
رمز التحديث: | 20221213 |
مُعرف محوري في PubMed: | PMC5702042 |
DOI: | 10.3389/fimmu.2017.01572 |
PMID: | 29209318 |
قاعدة البيانات: | MEDLINE |
تدمد: | 1664-3224 |
---|---|
DOI: | 10.3389/fimmu.2017.01572 |